Prasad Raju

CIK 00019683171 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001968317

Recent Transactions

42 trades

Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2026-03-23$46.78/sh−3,708→ 15,565 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2026-03-20+27,500→ 27,500 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2026-03-20+38,499→ 38,499 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2026-03-20+6,250→ 19,273 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2026-03-20−6,250→ 12,500 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2026-03-16$48.26/sh−5,848→ 17,794 total
Gift
CRISPR Therapeutics AG$CRSP
Common Shares
2026-03-16−750→ 13,023 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2026-03-16$48.26/sh−4,021→ 13,773 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2026-03-14+6,875→ 23,642 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2026-03-14−6,875→ 20,625 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2026-03-14−10,000→ 10,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2026-03-14+10,000→ 16,767 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2026-01-22$60.19/sh−34,972→ 6,767 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2026-01-22−34,972→ 41,667 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2026-01-22$45.15/sh+34,972→ 41,739 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2026-01-06−6,339→ 7,493 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2026-01-06$45.15/sh+23,361→ 30,128 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2026-01-06$44.31/sh+6,339→ 36,467 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2026-01-06$60.18/sh−18,933→ 17,534 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2026-01-06$60.00/sh−5,004→ 12,530 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2026-01-06$60.21/sh−5,763→ 6,767 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2026-01-06−23,361→ 76,639 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-10-03+16,500→ 16,500 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-05-30+20,000→ 20,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-21$41.23/sh−2,197→ 16,767 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-20+6,250→ 18,964 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-03-20−6,250→ 18,750 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-17$41.80/sh−3,762→ 12,714 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-03-14+36,666→ 36,666 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-03-14+27,500→ 27,500 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2025-03-14−10,000→ 20,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2025-03-14+10,000→ 16,476 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-10-16+15,000→ 15,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-10-16+18,333→ 18,333 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2024-03-20+36,168→ 36,168 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-03-20+25,000→ 25,000 total
Sale
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-15$72.69/sh−3,524→ 6,476 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Common Shares
2024-03-14+10,000→ 10,000 total
Exercise/Conversion
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2024-03-14−10,000→ 30,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2023-10-13+13,832→ 13,832 total
Award
CRISPR Therapeutics AG$CRSP
Restricted Stock Units
2023-03-14+40,000→ 40,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2023-03-14+100,000→ 100,000 total

Companies

CRISPR Therapeutics AG
Chief Financial Officer
$CRSP

Recent Filings

Address

C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET

BOSTON, MA, 02127

View on SEC.gov